Advisors To The Board

Scott Young 

Experienced investment banker with extensive cross-border transaction experience in Europe, North America, the Middle East and Asia, with executive positions at LF Rothschild (New York), Morgan Stanley (New York), Translink International (Paris and London) and Dial Partners LLP (London). Scott is founder and Managing Director of Gemini Capital in London. Until founding Gemini he was a Partner of Dial Partners in London, a corporate finance advisory firm assisting companies in mergers and acquisitions, capital raisings and other strategic initiatives.

Gemini Capital is involved in providing strategic and commercial advice to a wide range of entities, including private businesses, multinational companies, family offices, private equity groups and sovereign wealth funds. Through a wide range of contacts developed over 25 years with senior executives and officials with multinational corporations, government entities and financial institutions, Gemini provides valuable assistance to earlier stage companies who wish to gain high level access to both developed markets and emerging markets for their goods and services.
Scott was previously with Morgan Stanley & Company in New York in the International Capital Markets group. Earlier positions include corporate finance, fixed income and equity sales and syndication with LF Rothschild in New York and the US offices of the OECD in New York.  Scott received his Doctorate in Law and MBA degrees with distinction at the University of North Carolina at Chapel Hill.

Scott is particularly involved in the following areas:

  • Pioneering health care technologies (stem cell treatment for diabetes)
  • Alternative energy, renewables and energy efficiency, agriculture (biofuels, tree farming, irrigation technologies)
  • Water purification and conservation
  • Infrastructure (power generation, transport)

Among other activities Scott is a Board member of OmniCyte, the stem cell company conducting pioneering research to address a wide range of maladies including diabetes, liver disease, heart conditions and post-stroke care. The founder of the company is Professor Nagy Habib, Chair of Surgery at Imperial College in London (the largest medical infrastructure in Europe) and the Chairman of the company is Sir Richard Sykes, previously Chairman of GlaxoSmithKline PLC. 

Scott is on the fundraising committee of Great Ormond Street Children’s Hospital in London, one of the leading hospitals in the world for treating the most complex medical conditions faced by children. After living in Paris and Rio de Janeiro, Scott is fluent in French and Portuguese. 

© 2019 Globomass | Web Design by Granite Digital